Clinical Trials Directory

Trials / Completed

CompletedNCT02362399

Effect of Sildenafil Citrate on Uteri- Placental Perfusion, Doppler Indices in Growth Restricted Fetuses

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Al Hayat National Hospital · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

To detect the effect of sildenafil citrate on Doppler parameters in fetuses suffering from growth restriction to support its use later as prolonged therapy in those pregnancies at higher risk for such complication.

Detailed description

Participants were randomized in 1:1 ratio into one of the following drug regime: Group (I): "sildenafil citrate group" This group consisted of 22 women who received single oral dose of 50 mg sildenafil citrate. Group (II): "placebo group" This group consisted of 22 women who received single oral dose of placebo. All participants were evaluated by ultrasound once they admitted and again after 2-hours following administration of either of the treatment tablets. One sonographer was allocated to evaluate all mothers included in the study.

Conditions

Interventions

TypeNameDescription
DRUGsildenafil citratesingle oral dose of 50 mg
OTHERplacebosingle oral dose of placebo tablet

Timeline

Start date
2015-03-01
Primary completion
2016-04-01
Completion
2016-04-01
First posted
2015-02-12
Last updated
2016-04-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02362399. Inclusion in this directory is not an endorsement.